zonisamide) as monotherapy in the treatment of partial seizures, with or without secondary generalisation, in adults with newly diagnosed epilepsy and as adjunctive
therapy in the treatment of partial seizures, with or without secondary generalisation, in adults, adolescents and children aged six years and above.
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Perampanel as Adjunctive
Therapy in Patients with Refractory Partial-Onset Seizures from the Asia-Pacific Region
Nierenberg reported the "unexpected" result that, at 6 months, about a quarter of each group was observed to be doing well without any adjunctive
personalized treatments (23.
Patients were randomized in a 2:3:3 fashion to receive either adjunctive
L-methylfolate for 60 days (7.
Eslicarbazepine acetate is indicated as adjunctive
therapy in adults with partial onset seizures, with or without secondary generalisation (1).
The approval of BANZEL as adjunctive
treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in pediatric patients from 1 to 4 years of age is based on a pharmacokinetic bridging study of a Phase III clinical trial (study 303) which demonstrated the pharmacokinetic and safety profiles are consistent with those seen in ages 4 and above.
The proposed indication for the device is as adjunctive
therapy for reducing the frequency of seizures in adults with epilepsy characterized by partial-onset seizures that are refractory to antiepileptic medications.
A double-blind, placebo-controlled pivotal study of patients with LGS treated with BANZEL as adjunctive
therapy showed a 42.
Clinicians need to apply both the art and science of medicine when they consider atypical antipsychotics as adjunctive
therapy for the 10%-15% of patients who have inadequate response to conventional treatments for depression, several experts said in interviews.
Economical: The SinuCleanse System is an inexpensive adjunctive
therapy for patients with sinonasal disease.
George Papakostas will discuss various biomarkers and genotypes associated with major depression and those which may predict patient response to adjunctive
L-methylfolate, the bioavailable form of folate.
Key data at the American Epilepsy Society (AES) 69th Annual Meeting in Philadelphia, 4-8 December, will show results from 15 posters on the safety, efficacy, and long-term effects of adjunctive
Fycompa (perampanel) in patients with epilepsy.